Asaf Weinberger, CEO & FOUNDER has served as an officer (captain) engineer in the technological unit of the Israeli Defense Force for ten years. Following his military service, he was appointed as a representative of Israel Aircraft Industries in Southeast Asia. Asaf holds two degrees with distinction, an MBA and a B.Sc. in Mechanical Engineering, from the Technion, Israel Institute of Technology.

Dr. Miron Hazani, CTO has held senior R&D positions in leading companies in  the fields of microelectronics and nanotechnology.  Miron holds a Ph.D. in Biochemistry from Tel Aviv University, and conducted post-doctoral research  in chemical physics and nanotechnology at the  Weizmann Institute of Science, Israel.  Miron has invented all the technologies owned by Omega Life Science and its subsidiaries, including 4 aerosolization platforms and several formulations.  Miron developed the Laboratory Demonstrator and the Investigational Device.

Dr. Matan Dishon, VP of R&D brings a vast experience in both industrial and academic environments, dealing with medical devices, nano-science, biophysics, biochemistry and more.  Prior to joining Corolabs, Matan was CEO and Founder of SensEyez, a retinal imaging company.  He also served as CTO of O2Cure,  nanotechnology-based medical device developing a novel biomimetic, microfluidic based, gas-exchanger membrane for blood-oxygenators and artificial lungs and served as Chief Physicist at Palti Group, cluster of biomedical and medical device start-ups.  Matan holds a Ph.D. degree in Physics from the Technion Institute of Technology and taught there as an Assistant Professor.

Prof. Ori Rogowski MD, Head of the Scientific Board is one of Israel’s most eminent physicians, currently heading both (a) Internal Medicine “gimel” department in Ichilov hospital and (b) Corona department in Ichilov hospital.  Prof. Rogowski has been featured in television channel 13 news on 4/7/2020 as having successfully administered Dexamethasone and thus saving Corona patients in critical condition during the first wave, even before Dexamethasone was proven effective in a clinical trial by Oxford University.   Prof. Rogowski has been very supportive of Corolabs’ technology and value proposition and among other activities for the company he is leading the choice of drugs to be delivered using the Corolabs technology.